Predicting outcome after percutaneous balloon mitral commissurotomy : Role of neutrophil-lymphocyte ratio

A Separham1, L Pourafkari1,2, H Bodagh1

  • 1Cardiovascular Research Center, Tabriz University of Medical Science, Tabriz, Iran.

Herz
|November 1, 2016
PubMed
Abstract

Insights

The neutrophil-lymphocyte ratio (NLR) does not predict outcomes for percutaneous balloon mitral commissurotomy (PBMC). Mitral valve area and dilatation are key predictors of PBMC success and restenosis.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Inflammatory Markers

Background:

  • Severe mitral stenosis (MS) poses treatment challenges.
  • Predictive markers for percutaneous balloon mitral commissurotomy (PBMC) outcomes are valuable.
  • The role of neutrophil-lymphocyte ratio (NLR) in PBMC has not been established.

Purpose of the Study:

  • To investigate the predictive value of NLR in patients undergoing PBMC.
  • To correlate NLR with immediate procedural success and long-term restenosis.
  • To assess the relationship between NLR and mitral valve area (MVA) severity.

Main Methods:

  • Prospective enrollment of 102 patients with severe MS undergoing PBMC.
  • Calculation of NLR from complete blood cell counts on admission.
  • Evaluation of correlations between NLR, immediate PBMC success, and 1-year restenosis.

Main Results:

  • A higher NLR was associated with a smaller baseline MVA (p=0.016).
  • The overall immediate PBMC success rate was 63%.
  • NLR did not differ between patients with successful or failed procedures or those who developed restenosis.

Conclusions:

  • NLR on admission is not a useful predictor of PBMC procedural success.
  • NLR does not predict restenosis in patients undergoing PBMC for mitral stenosis.
  • Baseline MVA and procedural dilatation are independent predictors of PBMC outcomes.